Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04415684 · ClinicalTrials.gov registry record · NA
Projected Peripheral Defocus Using a Wearable Device
A NA study, sponsored by Kubota Vision.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04415684 is a NA study that has completed, run by Kubota Vision. The registered enrollment target is 26 participants.
The verdict
NCT04415684, a NA study, has completed, sponsored by Kubota Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery utilizing a wearable device will stimulate physiological changes similar to those in the literature.
Interventions
- DEVICE Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
- DEVICE No Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2020-08-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04415684
The ClinicalTrials.gov registry entry for NCT04415684 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kubota Vision, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.) is the first listed.
NCT04415684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04415684 about?
NCT04415684 is a clinical study titled "Projected Peripheral Defocus Using a Wearable Device". Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimped...
What is the current status of trial NCT04415684?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-06-29. Estimated completion is 2020-08-20.
What interventions are being tested in trial NCT04415684?
The interventions under investigation include: Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.) (DEVICE), No Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.) (DEVICE).
Who is sponsoring clinical trial NCT04415684?
This trial is sponsored by Kubota Vision, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.